Avid Bioservices Inc (CDMO)

[biopharm]

Rolf A. Stahel is current President of ESMO...

Interesting video below re: Rolf Stahel as he states:

"Everybody develops cancer all the time and the immune system gets rid of it. However, the tumors have developed mechanisms that they can fight off the immune system and they can find ways by secreting factors which block the immune cells or by having on the surface, receptors, which when the immune cells hit those receptors, they go inactive. Now, Immuno-Oncology is the idea to enable the immune system to fight back the cancer.."

"Immuno-Oncology for most of the part is clinical trials, but there have been agents - immune checkpoint inhibitors that have regulatory approval for clinical use. The thing is though, the results are...good, but there is so much more hope for better results that I would think that most of the physicians or centers that deal with Immuno-Oncology would like to treat the patient in trials to give him an even better chance than what is already available"

http://www.ecpc.org/Documents/Policy&Advocacy/Immuno-Oncology/Event%2019th%20Nov%202014/IO%20patients%20leaflet.pdf

Did everyone in the boat hear that?

"I would think that most of the physicians or centers that deal with Immuno-Oncology would like to treat the patient in trials to give him an even better chance that what is already available"

...and that is coming from the President of the ESMO and sure sounds like this paradigm shift in medical treatment is happening so fast, that if the docs are aware of what is looming out there in PS Targeting land, that trials are where you will find your best chance for an even better chance than what is already available.